The Prolyl 3-Hydroxylases P3H2 and P3H3 Are Novel Targets for Epigenetic Silencing in Breast Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6605042
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prolyl Hydroxylases and Therapeutics

Antioxidants and Redox Signaling
Cell BiologyMolecular BiologyBiochemistryClinical BiochemistryMedicinePhysiology
2010English

Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Cancer Research
Cancer ResearchOncology
2011English

Luminal-B Breast Cancer and Novel Therapeutic Targets

Breast Cancer Research
Cancer ResearchOncology
2011English

Epigenetic Silencing of SOD2 by Histone Modifications in Human Breast Cancer Cells

Free Radical Biology and Medicine
BiochemistryPhysiology
2008English

Scanning the Human Genome for Novel Therapeutic Targets for Breast Cancer

2003English

Identification of Novel Therapeutic Targets for Triple-Negative Breast Cancer

2012English

Epigenetic Silencing of TCEAL7 (Bex4) in Ovarian Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2005English

PIAS1 Regulates Breast Tumorigenesis Through Selective Epigenetic Gene Silencing

PLoS ONE
Multidisciplinary
2014English

Epigenetic Silencing of Protocadherin 10 in Colorectal Cancer (Review)

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy